| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 06/09/2010 | EP1497273B1 Hydroxamic acid derivatives |
| 06/09/2010 | EP1292308B1 Alpha,beta-unsaturated sulfones for treating proliferative disorders |
| 06/09/2010 | CN1914152B New compounds, methods for their preparation and use thereof |
| 06/09/2010 | CN1910144B Sulfonamide derivatives for the treatment of diseases |
| 06/09/2010 | CN101730693A Process for producing macrolide compound and intermediate therefor |
| 06/09/2010 | CN101724099A Aromatic ketone compound and photoinitiator with same |
| 06/09/2010 | CN101723977A 1-(2-phenyl indenyl) dicyclohexylphosphonium tetrafluoroborate as well as preparation method and application thereof |
| 06/09/2010 | CN101723921A CaSR antagonist |
| 06/09/2010 | CN101723918A Process for preparing cinepazide maleate |
| 06/09/2010 | CN101723771A Novel method for preparing beta-aminoketone, ester, nitrile and amide derivatives through catalysis of functional ionic liquid |
| 06/09/2010 | CN101062923B Synthesizing N-formyl morpholine by two-step process |
| 06/08/2010 | US7732451 Naphthalene-containing melanocortin receptor-specific small molecule |
| 06/08/2010 | US7732449 preferential enzyme Inhibitors such as 4-(4-Acetyl-piperazin-1-yl)-2-(R)-cyclohexylmethyl-N-[1-(S)-methyl-2-(4-trifluoromethoxy-phenylamino)-ethyl]-4-oxo-butyramide, used for the treatment of inflammation, arthritis and atherosclerosis |
| 06/08/2010 | US7732429 Reducing tetracycline resistance in living cells |
| 06/08/2010 | US7731940 N-(2-[4-(2-methoxyphenyl)piperazinyl]ethyl)-N-(2-pyridyl)-N-(4-18F-fluoro-methylcyclohexane)carboxamide, used for treating panic, bipolar or seizure disorders, and as a quantitative tool for measuring serotonin concentration in the brain |
| 06/03/2010 | US20100137588 Method for preparing ortho-substituted aminoferrocenes |
| 06/03/2010 | US20100137335 Metabolites of (thio) carbamoyl-cyclohexane derivatives |
| 06/03/2010 | US20100137334 Piperidine and Piperazine Derivatives |
| 06/03/2010 | US20100137329 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 06/03/2010 | US20100137291 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 06/03/2010 | US20100137250 Naphthylacetic acids |
| 06/02/2010 | EP2192108A1 Novel dihydronaphthalene compound and use thereof |
| 06/02/2010 | EP2190827A1 N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators |
| 06/02/2010 | EP2190814A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 06/02/2010 | EP1828142B1 Method for producing onium alkyl sulfates with a low halogenide content |
| 06/02/2010 | EP1773772B1 New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission |
| 06/02/2010 | EP1483228B1 Nk1 antagonists |
| 06/02/2010 | EP1326833B1 Substituted heterocyclic compounds for treating multidrug resistance |
| 06/02/2010 | CN101717382A Method for synthesizing cinepazide |
| 06/02/2010 | CN101168532B Method for synthesizing N-methylpiperazine substituted anilin |
| 06/01/2010 | US7728148 Acyclic oximyl hepatitis C protease inhibitors |
| 06/01/2010 | US7728032 biphenyl heterocycle derivatives; atherosclerosis, thrombosis, stroke, acute coronary syndrome, stable angina, peripheral vascular disease, ischemia, intermittent claudication, abdominal aortic aneurysm, myocardial infarction; 2-(4-Benzyloxy-phenoxymethyl)-pyrrolidine-1-carboxylic acid tert-butyl ester |
| 06/01/2010 | US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 06/01/2010 | US7727991 Substituted melanocortin receptor-specific single acyl piperazine compounds |
| 06/01/2010 | US7727990 Agonist or antgonist and binders and inversion of agonist; use in the treatment of metabolic, immune, infection-related and melanocortin receptor mediated disorders including specifically treatment of obesity and related conditions |
| 06/01/2010 | CA2400626C Estrogen receptor modulators |
| 05/27/2010 | WO2010058774A1 Solid heavy metal processing agent, method for producing same and use of same |
| 05/27/2010 | WO2010057874A1 Process for preparing secondary amides by carbonylation of a corresponding tertiary amine |
| 05/27/2010 | WO2010057515A1 Levocetirizine by menthyl intermediate |
| 05/27/2010 | WO2009129387A3 Cationic lipids and uses thereof |
| 05/27/2010 | US20100130737 Regulating Agent of GPR34 Receptor Function |
| 05/27/2010 | US20100130507 Prostaglandin derivatives |
| 05/27/2010 | US20100130497 Therapeutic Compounds |
| 05/27/2010 | US20100127210 Liquid crystal compounds and liquid crystal compositions comprising the same |
| 05/27/2010 | CA2743733A1 Process for preparing secondary amides by carbonylation of a corresponding tertiary amine |
| 05/26/2010 | EP2189441A1 Process for preparing secondary amides by carbonylation of a corresponding tertiary amine |
| 05/26/2010 | EP2189439A2 CaSR antagonist |
| 05/26/2010 | EP2188269A1 New compounds |
| 05/26/2010 | EP1968960B1 Racemic separation of 2,6-trans-dimethylmorpholine |
| 05/26/2010 | EP1730103B1 Formamide derivatives useful as adrenoceptor |
| 05/26/2010 | CN1942427B Indene derivatives and process for the preparation thereof |
| 05/26/2010 | CN1849117B Entry inhibitors of the HIV virus |
| 05/26/2010 | CN1596113B Use of delta receptor agonist compound in preparing medicine for treating depression |
| 05/26/2010 | CN1391469B Npyy5拮抗剂 Npyy5 antagonist |
| 05/26/2010 | CN101712660A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 05/26/2010 | CN101712659A Compound with platelet aggregation resisting activity and preparation method thereof |
| 05/26/2010 | CN101712658A 1-butyl-2-hydroxy aralkyl piperazine derivative and application as antidepressant |
| 05/26/2010 | CN101712640A methods and compositions for treating amyloid-related diseases |
| 05/26/2010 | CN101712632A Substituted tetracycline compounds |
| 05/25/2010 | USRE41356 Hepatitis C inhibitor tri-peptides |
| 05/25/2010 | US7723519 high binding efficiencies between D3 and D2 dopaminergic receptor subtypes; drug abuse, drug dependence |
| 05/25/2010 | US7723377 Inhibitors of cognitive decline |
| 05/25/2010 | US7723338 Crystalline forms of 1-benzoyl-4-[2-[4,7-dimethoxy-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-yl]-1,2-dioxoethyl]-piperazine |
| 05/25/2010 | US7723337 3-cinnolinecarboxamide derivatives and their use for treating cancer |
| 05/25/2010 | US7723325 such as [5-(4-cyclopentyl-piperazine-1-carbonyl)-1H-indol-2-yl]-pyrrolidin-1-yl-methanone, useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors |
| 05/25/2010 | CA2440518C Method of producing n-substituted 2,6-dialkyl morpholines |
| 05/25/2010 | CA2415178C 9-substituted minocycline compounds |
| 05/20/2010 | WO2010056527A2 Fused heterocyclic compounds as ion channel modulators |
| 05/20/2010 | WO2010055006A1 Naphthylacetic acids used as crth2 antagonists or partial agonists |
| 05/20/2010 | WO2010055005A1 Naphthylacetic acids |
| 05/20/2010 | WO2010055004A1 Naphthylacetic acids |
| 05/20/2010 | US20100125076 Substituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use |
| 05/20/2010 | US20100125075 Antibacterial Agents |
| 05/20/2010 | CA2780624A1 Isoprenyl compounds and methods thereof |
| 05/20/2010 | CA2740864A1 Naphthylacetic acids |
| 05/20/2010 | CA2740863A1 Naphthylacetic acids |
| 05/20/2010 | CA2739725A1 Naphthylacetic acids used as crth2 antagonists or partial agonists |
| 05/19/2010 | EP2186803A2 Substituted thioacetamides |
| 05/19/2010 | EP2186793A1 Substituted Tetracycline Compounds |
| 05/19/2010 | EP2185499A1 Method for producing amines from glycerin |
| 05/19/2010 | EP1575575B1 Safe chemical uncouplers for the treatment of obesity |
| 05/19/2010 | EP1371646B1 Aryl-substituted alicyclic compound and medical composition comprising the same |
| 05/19/2010 | CN1962649B Process for synthesizing N-ethyl piperazidine |
| 05/18/2010 | US7718802 Substituted melanocortin receptor-specific piperazine compounds |
| 05/18/2010 | US7718675 Diamino alcohols and their use as renin inhibitor |
| 05/18/2010 | US7718657 Certain indanyl urea modulators of the cardiac sarcomere |
| 05/18/2010 | US7718650 Piperazino or diazepino-substituted arylsulfonamides; obesity, type II diabetes and/or central nervous system disorders; 4-chloro-N-[5-(4-methyl-1,4-diazepan-1-yl)-2-nitrophenyl]benzenesulfonamide for example; Serotonin 5-HT6 receptor antagonist activity |
| 05/18/2010 | US7718646 Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same |
| 05/14/2010 | WO2010051935A2 Substituted amido phenoxybenzamides |
| 05/12/2010 | EP2184073A1 Therapeutic agent for cancer with resistance to protease inhibitor |
| 05/12/2010 | EP2183217A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 05/12/2010 | EP1856073B1 A PROCESS FOR THE PREPARATION OF AN 11-(4-SUBSTITUTED-I-PIPERAZINYL)DIBENZO[b,f][1,4]THIAZEPINE DERIVATIVE |
| 05/12/2010 | CN1944424B Aryl formyl piperazine compound and its preparing method and use in medicine production |
| 05/12/2010 | CN101704810A Cycloalkyl inhibitors of potassium channel function |
| 05/12/2010 | CN101704801A Cinepazide oxynitride, and preparation method and applications thereof |
| 05/12/2010 | CN101182304B Method for preparing N-alkyl pyrrolidine |
| 05/12/2010 | CN101068798B Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine |
| 05/12/2010 | CN101062922B Method for preparing N-formyl morpholine |
| 05/11/2010 | US7714170 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis |
| 05/11/2010 | US7714131 Process for the stereoselective preparation of (−)-halofenate and derivatives thereof |